Citations (37)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Abhinav Kumar, John P J Rocke & B Nirmal Kumar. (2020) Evolving treatments in high-risk neuroblastoma. Expert Opinion on Orphan Drugs 8:12, pages 497-506.
Read now
Read now
Atif A. Ahmed, Lei Zhang, Naresh Reddivalla & Maxine Hetherington. (2017) Neuroblastoma in children: Update on clinicopathologic and genetic prognostic factors. Pediatric Hematology and Oncology 34:3, pages 165-185.
Read now
Read now
Anneleen Decock, Maté Ongenaert, Bram De Wilde, Bénédicte Brichard, Rosa Noguera, Frank Speleman & Jo Vandesompele. (2016) Stage 4S neuroblastoma tumors show a characteristic DNA methylation portrait. Epigenetics 11:10, pages 761-771.
Read now
Read now
Articles from other publishers (34)
Yongbo Yu, Meng Zhang, Xingfeng Yao, Xiaoxing Guan, Chao Jia, Ping Chu, Ruqian Zhang, Yeran Yang, Yaqiong Jin, Huanmin Wang, Xin Ni, Lejian He & Yongli Guo. (2023)
Translational practice of fluorescence
in situ
hybridisation to identify neuroblastic tumours with
TERT
rearrangements
. The Journal of Pathology: Clinical Research.
Crossref
Crossref
Hannah G. Bender, Meredith S. Irwin, Michael D. Hogarty, Robert Castleberry, John M. Maris, Pei-Chi Kao, Fan F. Zhang, Arlene Naranjo, Susan L. Cohn & Wendy B. London. (2023) Survival of Patients With Neuroblastoma After Assignment to Reduced Therapy Because of the 12- to 18-Month Change in Age Cutoff in Children's Oncology Group Risk Stratification. Journal of Clinical Oncology 41:17, pages 3149-3159.
Crossref
Crossref
Mirjam Blattner-Johnson, David T.W. Jones & Elke Pfaff. (2022) Precision medicine in pediatric solid cancers. Seminars in Cancer Biology 84, pages 214-227.
Crossref
Crossref
Eun Young Yu, Nai-Kong V. Cheung & Neal F. Lue. (2022) Connecting telomere maintenance and regulation to the developmental origin and differentiation states of neuroblastoma tumor cells. Journal of Hematology & Oncology 15:1.
Crossref
Crossref
Steven G. DuBois, Margaret E. Macy, & Tara O. Henderson. (2022) High-Risk and Relapsed Neuroblastoma: Toward More Cures and Better Outcomes. American Society of Clinical Oncology Educational Book:42, pages 768-780.
Crossref
Crossref
Joon Hyuk Choi & Jae Y. Ro. (2022) Mediastinal neuroblastoma, ganglioneuroblastoma, and ganglioneuroma: Pathology review and diagnostic approach. Seminars in Diagnostic Pathology 39:2, pages 120-130.
Crossref
Crossref
Iedan R. N. Verly, Yvette A. H. Matser, René Leen, Rutger Meinsma, Marta Fiocco, Jan Koster, Richard Volckmann, Dilara Savci-Heijink, Giuliana Cangemi, Sebastiano Barco, Linda J. Valentijn, Godelieve A. M. Tytgat & André B. P. van Kuilenburg. (2022) Urinary 3-Methoxytyramine Is a Biomarker for MYC Activity in Patients With Neuroblastoma. JCO Precision Oncology:6.
Crossref
Crossref
Nida Usmani, Rebecca J. Deyell, Carol Portwine, Margarida Simao Rafael, Paul C. Moorehead, Amer Shammas, Reza Vali, Mateo Farfan, Thuvaraha Vanniyasingam, Daniel A. Morgenstern & Meredith S. Irwin. (2021) Residual meta‐iodobenzyl guanidine (MIBG) positivity following therapy for metastatic neuroblastoma: Patient characteristics, imaging, and outcome. Pediatric Blood & Cancer 68:12.
Crossref
Crossref
Eun Young Yu, Syed S. Zahid, Sarah Aloe, Erik Falck-Pedersen, Xi Kathy Zhou, Nai-Kong V. Cheung & Neal F. Lue. (2021) Reciprocal impacts of telomerase activity and ADRN/MES differentiation state in neuroblastoma tumor biology. Communications Biology 4:1.
Crossref
Crossref
Meredith S. Irwin, Arlene Naranjo, Fan F. Zhang, Susan L. Cohn, Wendy B. London, Julie M. Gastier-Foster, Nilsa C. Ramirez, Ruthann Pfau, Shalini Reshmi, Elizabeth Wagner, Jed Nuchtern, Shahab Asgharzadeh, Hiroyuki Shimada, John M. Maris, Rochelle Bagatell, Julie R. Park & Michael D. Hogarty. (2021) Revised Neuroblastoma Risk Classification System: A Report From the Children's Oncology Group. Journal of Clinical Oncology 39:29, pages 3229-3241.
Crossref
Crossref
Jesmin Akter & Takehiko Kamijo. (2021) How Do Telomere Abnormalities Regulate the Biology of Neuroblastoma?. Biomolecules 11:8, pages 1112.
Crossref
Crossref
A. B. Demir, Safiye Aktas, Z. Altun, P. Ercetin, T. C. Aktas & N. Olgun. (2021) Questioning How to Define the “Ultra-High-Risk” Subgroup of Neuroblastoma Patients. Folia Biologica 67:1, pages 1-9.
Crossref
Crossref
Beatriz Fernández-Blanco, Ana Pilar Berbegall, Susana Martin-Vañó, Victoria Castel, Samuel Navarro & Rosa Noguera. (2021) Imbalance between genomic gain and loss identifies high-risk neuroblastoma patients with worse outcomes. Neoplasia 23:1, pages 12-20.
Crossref
Crossref
Herbert W. Kappauf. 2020. Kompendium Internistische Onkologie. Kompendium Internistische Onkologie
1
8
.
S. L. George, V. Parmar, F. Lorenzi, L. V. Marshall, Y. Jamin, E. Poon, P. Angelini & L. Chesler. (2020) Novel therapeutic strategies targeting telomere maintenance mechanisms in high-risk neuroblastoma. Journal of Experimental & Clinical Cancer Research 39:1.
Crossref
Crossref
Samuel W. Brady, Yanling Liu, Xiaotu Ma, Alexander M. Gout, Kohei Hagiwara, Xin Zhou, Jian Wang, Michael Macias, Xiaolong Chen, John Easton, Heather L. Mulder, Michael Rusch, Lu Wang, Joy Nakitandwe, Shaohua Lei, Eric M. Davis, Arlene Naranjo, Cheng Cheng, John M. Maris, James R. Downing, Nai-Kong V. Cheung, Michael D. Hogarty, Michael A. Dyer & Jinghui Zhang. (2020) Pan-neuroblastoma analysis reveals age- and signature-associated driver alterations. Nature Communications 11:1.
Crossref
Crossref
I. V. Kazantsev, A. G. Gevorgyan, T. V. Yukhta, P. S. Tolkunova, A. V. Kozlov, D. A. Zvyagintseva, M. S. Golenkova, O. I. Bogdanova, A. N. Shvetsov, E. V. Morozova, I. Yu. Nikolaev, S. A. Safonova, Yu. A. Punanov, L. S. Zubarovskaya & B. V. Afanasyev. (2020) Clinical and biological characteristics of neuroblastoma in adolescents and young adults. Case study and literature review. Russian Journal of Pediatric Hematology and Oncology 7:3, pages 13-21.
Crossref
Crossref
Balakrishna Koneru, Gonzalo Lopez, Ahsan Farooqi, Karina L. Conkrite, Thinh H. Nguyen, Shawn J. Macha, Apexa Modi, Jo Lynne Rokita, Eduardo Urias, Ashly Hindle, Heather Davidson, Kristyn Mccoy, Jonas Nance, Vanda Yazdani, Meredith S. Irwin, Shengping Yang, David A. Wheeler, John M. Maris, Sharon J. Diskin & C. Patrick Reynolds. (2020) Telomere Maintenance Mechanisms Define Clinical Outcome in High-Risk Neuroblastoma. Cancer Research 80:12, pages 2663-2675.
Crossref
Crossref
Harriet E. D. Southgate, Lindi Chen, Nicola J. Curtin & Deborah A. Tweddle. (2020) Targeting the DNA Damage Response for the Treatment of High Risk Neuroblastoma. Frontiers in Oncology 10.
Crossref
Crossref
Hui-Ching Chuang, Hung-Yu Lin, Pei-Lin Liao, Chao-Cheng Huang, Li-Ling Lin, Wen-Ming Hsu & Jiin-Haur Chuang. (2020) Immunomodulator polyinosinic-polycytidylic acid enhances the inhibitory effect of 13-cis-retinoic acid on neuroblastoma through a TLR3-related immunogenic-apoptotic response. Laboratory Investigation 100:4, pages 606-618.
Crossref
Crossref
Kai Duan, Brendan C. Dickson, Paula Marrano, Paul S. Thorner & Catherine T. Chung. (2019) Adult‐onset neuroblastoma: Report of seven cases with molecular genetic characterization. Genes, Chromosomes and Cancer 59:4, pages 240-248.
Crossref
Crossref
Gudrun Schleiermacher. 2020. Neuroblastoma. Neuroblastoma
17
28
.
Meredith S. Irwin. 2020. Neuroblastoma. Neuroblastoma
271
292
.
Jing Yang, Xiaojun Shao, Lingzhen Wang, Huijuan Xu, Yan Sun, Jian Jiang & Lirong Sun. (2019)
Angelica
polysaccharide exhibits antitumor effect in neuroblastoma cell line SH‐SY5Y by up‐regulation of miR‐205
. BioFactors.
Crossref
Crossref
Ackermann & Fischer. (2019) Telomere Maintenance in Pediatric Cancer. International Journal of Molecular Sciences 20:23, pages 5836.
Crossref
Crossref
Laura C. McCarthy, Katherine Chastain, Terrie G. Flatt, Eugenio Taboada, Robert Garola, John Herriges, Linda D. Cooley & Atif A. Ahmed. (2019) Neuroblastoma in Adolescents and Children Older than 10 Years: Unusual Clinicopathologic and Biologic Features. Journal of Pediatric Hematology/Oncology 41:8, pages 586-595.
Crossref
Crossref
Rose Chami, Paula Marrano, Chinachote Teerapakpinyo, Anthony Arnoldo, Mary Shago, Shanop Shuangshoti & Paul S. Thorner. (2019) Immunohistochemistry for ATRX Can Miss ATRX Mutations. American Journal of Surgical Pathology 43:9, pages 1203-1211.
Crossref
Crossref
Eun Young Yu, Irene Y. Cheung, Yi Feng, Mohamed O. Rabie, Gail J. Roboz, Monica L. Guzman, Nai-Kong V. Cheung & Neal F. Lue. (2019) Telomere Trimming and DNA Damage as Signatures of High Risk Neuroblastoma. Neoplasia 21:7, pages 689-701.
Crossref
Crossref
Jay F. Sarthy, Steven Henikoff & Kami Ahmad. (2019) Chromatin Bottlenecks in Cancer. Trends in Cancer 5:3, pages 183-194.
Crossref
Crossref
Jamie I. Fletcher, David S. Ziegler, Toby N. Trahair, Glenn M. Marshall, Michelle Haber & Murray D. Norris. (2018) Too many targets, not enough patients: rethinking neuroblastoma clinical trials. Nature Reviews Cancer 18:6, pages 389-400.
Crossref
Crossref
Tiago Bordeira Gaspar, Ana Sá, José Manuel Lopes, Manuel Sobrinho-Simões, Paula Soares & João Vinagre. (2018) Telomere Maintenance Mechanisms in Cancer. Genes 9:5, pages 241.
Crossref
Crossref
I.R.N. Verly, A.B.P. van Kuilenburg, N.G.G.M. Abeling, S.M.I. Goorden, M. Fiocco, F.M. Vaz, M.M. van Noesel, C.M. Zwaan, G.J.L. Kaspers, J.H.M. Merks, H.N. Caron & G.A.M. Tytgat. (2018) 3-Methoxytyramine: An independent prognostic biomarker that associates with high-risk disease and poor clinical outcome in neuroblastoma patients. European Journal of Cancer 90, pages 102-110.
Crossref
Crossref
Xiao-Feng Duan & Qiang Zhao. (2018) TERT-mediated and ATRX-mediated Telomere Maintenance and Neuroblastoma. Journal of Pediatric Hematology/Oncology 40:1, pages 1-6.
Crossref
Crossref
Elisa Izquierdo, Lina Yuan, Sally George, Michael Hubank, Chris Jones, Paula Proszek, Janet Shipley, Susanne A. Gatz, Caedyn Stinson, Andrew S. Moore, Steven C. Clifford, Debbie Hicks, Janet C. Lindsey, Rebecca M. Hill, Thomas S. Jacques, Jane Chalker, Khin Thway, Simon O’Connor, Lynley Marshall, Lucas Moreno, Andrew Pearson, Louis Chesler, Brian A. Walker & David Gonzalez De Castro. (2017) Development of a targeted sequencing approach to identify prognostic, predictive and diagnostic markers in paediatric solid tumours. Oncotarget 8:67, pages 112036-112050.
Crossref
Crossref